Illumina Completes Executive Leadership Overhaul with Appointment of New CEO and CCO

On June 4, 2024, Illumina announcedEverett Cunningham will serve as the company's Chief Commercial Officer (CCO).

This person is no stranger to us either—this is the former CCO of Exact Sciences.

Everett graduated from Northwestern University in 1990 with a degree in economics.

Subsequently, he joined Pfizer as a sales representative (medical representative) and was promoted to senior director in just 7 years.

In 2003, the title reached VP (Vice President), and in 2019, the position of President was obtained.

Left Pfizer after 21 years of work in 2012, then joined Quest, a testing giant, as the Senior Vice President (SVP) of Business.

In 2019, he took a further step by joining GE Healthcare as the President and CEO of USCAN (United States and Canada).

Joined Exact Sciences in 2021 as CCO (Chief Commercial Officer).

At this point, Illumina's management team has finally been completely and comprehensively replaced, truly a case of "out with the old, in with the new."

Let's review the timeline of management changes:

On April 9, 2024, CFO Joydeep Goswami stepped down, and Ankur Dhingra became the CFO;

On February 26, 2024, Illumina announced that Jenny Zheng (郑磊) will serve as the Head of Greater China for Illumina.

On January 4, 2024, CCO Susan Tousi resigned;

On September 20, 2023, Li Qing, Head of Illumina China, resigned.

On September 8, 2023, Illumina announced that Dr. Phillip G. Febbo, the company's CMO (Chief Medical Officer), had left the company on August 7, 2023.

On September 5, 2023, Illumina announced that the Board of Directors appointed Dr. Jacob Thaysen as the new CEO.

On August 9, 2023, CTO Alex Aravanis resigned;

On June 11, 2023, Illumina announced that CEO Francis deSouza had left the company, effective June 11, 2023.

Of course, up to this point, as a bystander blogger, I am still not qualified.

In fact, the management adjustment of Illumina is not limited to this.

In January 2024, Chief People Officer Aimee Hoyt departed, and former VP of Human Resources Pat Leckman took over the position.

On March 22, 2024, Illumina's Chief Marketing Officer, Kathryne Reeves, departed from her position, and there is currently no successor.

In other words, there are still no successors for the positions of Chief Medical Officer and Chief Marketing Officer.

Everyone, would you like to consider it?

Finally, the juiciest gossip:

Back when Jacob first announced he was taking over Illumina, Pat Leckman immediately reposted and commented, but Aimee Hoyt did not (or perhaps deleted it later).

You see, the boss posted on Moments and asked us to forward, comment, and like it.

If you like it, one-click three actions: like, favorite, and share.！